Trial of Oxytocin Alone Versus Oxytocin and Propranolol for the Treatment of Abnormal Labor
Withdrawn before enrolling · Phase 2 · Has a placebo group
Conditions studied: Dysfunctional Labor
In brief
The purpose of this study is to determine whether propranolol is better than oxytocin for the treatment of labor abnormalities. The endpoint is the rate of vaginal delivery experienced by women receiving prolonged oxytocin versus propranolol.
Key facts
- Study ID
- NCT00315913
- Run by
- University of California, Irvine
- People needed
- 0
- Starts
- 2004-01-01
- Expected to finish
- 2008-03-01
- Last updated by the study team
- 2019-02-27
Who can join
Age: 18 and older. Sex: female. Healthy volunteers: accepted.
You may qualify if…
- Must be term pregnancy (> 37 weeks)
- Vertex presentation
- Active labor (4-5 centimeters dilated)
You may not qualify if…
- Heart disease
- Diabetes
- Currently taking propranolol
- Contraindications to labor or vaginal delivery
- Multiple gestations
- Preterm
- Chorioamnionitis
Where it is running
- Long Beach Memorial Medical Center — Long Beach, California, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.